Back

CCG interruptions are unstable and hypermethylated in DM1 patients

Lameiras, S.; Lampraki, E. M.; Kilburn, D.; Alaeitabar, T.; Jamail, I.; Servant, N.; Baulande, S.; Kingan, S. B.; Holt, S.; Gaysinskaya, V.; Brandine, G. D. S.; Stucki, D.; Stojkovic, T.; Bassez, G.; Furling, D.; Gourdon, G.; Tome, S.

2024-10-10 molecular biology
10.1101/2024.10.10.617614 bioRxiv
Show abstract

Myotonic dystrophy type 1 (DM1) exhibits highly heterogeneous clinical manifestations caused by an unstable CTG repeat expansion reaching up to 4,000 CTG. The dynamics of CTG repeats and clinical variability depends on the CTG repeat number, CNG repeat interruptions, DNA methylation, somatic mosaicism, but also gene modifiers. Around 10% of the DM1 population carries triplet repeat interruptions (CCG, CGG, CTC, CAG), which differ in number and nature between DM1 families. CCG interruptions have been associated with stabilization of the CTG repeat expansions and a milder phenotype in the DM1 population. However, the dynamics and precise role of interruptions in CTG repeat instability remain relatively underexplored due to the complexities of analyzing them. In this study, we showed that the number of CCG interruptions within the expansion varies within tissues and between generations using single-molecule real-time long-read sequencing. Although the interrupted expanded alleles showed global stabilization, the CCG interruptions themselves displayed variability across generations and within somatic tissues. Importantly, our findings reveal, for the first time, CCG hypermethylation within the CTG expansion, which is linked to downstream hypermethylation of the repeat. These results support the hypothesis that methylation of CCG interruptions within the expanded DMPK alleles may contribute to the stabilization of trinucleotide repeats.

Matching journals

The top 6 journals account for 50% of the predicted probability mass.

1
Human Molecular Genetics
130 papers in training set
Top 0.1%
26.9%
2
Scientific Reports
3102 papers in training set
Top 8%
8.7%
3
Human Mutation
29 papers in training set
Top 0.1%
5.0%
4
International Journal of Molecular Sciences
453 papers in training set
Top 1%
5.0%
5
Neurobiology of Disease
134 papers in training set
Top 2%
3.4%
6
Cells
232 papers in training set
Top 1%
2.2%
50% of probability mass above
7
Genome Medicine
154 papers in training set
Top 3%
2.2%
8
Nature Communications
4913 papers in training set
Top 48%
2.0%
9
eLife
5422 papers in training set
Top 39%
1.9%
10
Nucleic Acids Research
1128 papers in training set
Top 10%
1.7%
11
EMBO Molecular Medicine
85 papers in training set
Top 2%
1.5%
12
Clinical and Translational Medicine
30 papers in training set
Top 0.4%
1.5%
13
Molecular Therapy - Nucleic Acids
24 papers in training set
Top 0.1%
1.4%
14
The Journal of Molecular Diagnostics
36 papers in training set
Top 0.3%
1.4%
15
Disease Models & Mechanisms
119 papers in training set
Top 1%
1.4%
16
Frontiers in Genetics
197 papers in training set
Top 6%
1.4%
17
BMC Medical Genomics
36 papers in training set
Top 0.7%
1.3%
18
npj Genomic Medicine
33 papers in training set
Top 0.5%
1.3%
19
Communications Biology
886 papers in training set
Top 13%
1.3%
20
PLOS ONE
4510 papers in training set
Top 59%
1.3%
21
Journal of Advanced Research
15 papers in training set
Top 0.3%
1.3%
22
BMC Genomics
328 papers in training set
Top 4%
1.0%
23
Frontiers in Cell and Developmental Biology
218 papers in training set
Top 6%
1.0%
24
PLOS Genetics
756 papers in training set
Top 12%
1.0%
25
Genomics, Proteomics & Bioinformatics
171 papers in training set
Top 5%
0.8%
26
Open Biology
95 papers in training set
Top 2%
0.8%
27
JCI Insight
241 papers in training set
Top 7%
0.8%
28
Acta Neuropathologica Communications
81 papers in training set
Top 1%
0.8%
29
Genome Research
409 papers in training set
Top 4%
0.8%
30
Arthritis & Rheumatology
33 papers in training set
Top 0.5%
0.7%